ulipristal acetate has been researched along with Breast Cancer in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, H; Ha, R; Hibshoosh, H; Pike, MC; Polaneczky, M; Wang, Z; Westhoff, CL | 1 |
| Bosland, MC; Clare, SE; Helenowski, I; Hosseini, O; Khan, SA; Kim, JJ; Lee, O; Patel, P; Schipma, MJ; Shidfar, A; Wang, M; Xuei, X | 1 |
| Critchley, HO; Whitaker, LH; Williams, AR | 1 |
| Chabbert-Buffet, N; Esber, N; Le Billan, F; Lombès, M; Loosfelt, H; Resche-Rigon, M | 1 |
| Alami, M; Chabbert-Buffet, N; Cherbonnier, C; Esber, N; Fagart, J; Hamze, A; Lombès, M; Loosfelt, H; Resche-Rigon, M | 1 |
| Chaouat, M; Chauvet, MP; Communal, L; Courtin, A; Delaloge, S; Feunteun, J; Forgez, P; Gompel, A; Hugon-Rodin, J; Lahlou, N; Le Guillou, M; Mourra, N; Perrault de Jotemps, M; Pujol, P; Vilasco, M | 1 |
1 review(s) available for ulipristal acetate and Breast Cancer
| Article | Year |
|---|---|
Selective progesterone receptor modulators.
Topics: Breast Neoplasms; Contraceptives, Postcoital; Endometriosis; Female; Hormone Antagonists; Humans; Leiomyoma; Menorrhagia; Norpregnadienes; Quality of Life; Receptors, Progesterone; Uterine Neoplasms | 2014 |
1 trial(s) available for ulipristal acetate and Breast Cancer
| Article | Year |
|---|---|
The progesterone-receptor modulator, ulipristal acetate, drastically lowers breast cell proliferation.
Topics: Adolescent; Adult; Breast Neoplasms; Cell Proliferation; Female; Humans; Leiomyoma; Norpregnadienes; Progesterone; Receptors, Progesterone; Young Adult | 2022 |
4 other study(ies) available for ulipristal acetate and Breast Cancer
| Article | Year |
|---|---|
Selective progesterone receptor blockade prevents BRCA1-associated mouse mammary tumors through modulation of epithelial and stromal genes.
Topics: Animals; BRCA1 Protein; Breast Neoplasms; Carcinogenesis; Disease Models, Animal; Epithelial Cells; Female; Humans; Mammary Glands, Animal; Mastectomy; Mice; Mifepristone; Norpregnadienes; Receptors, Progesterone; Stromal Cells; Tumor Microenvironment | 2021 |
Ulipristal Acetate Inhibits Progesterone Receptor Isoform A-Mediated Human Breast Cancer Proliferation and BCl2-L1 Expression.
Topics: bcl-X Protein; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Humans; Norpregnadienes; Progesterone; Receptors, Progesterone | 2015 |
Anti-Tumoral Effects of Anti-Progestins in a Patient-Derived Breast Cancer Xenograft Model.
Topics: Androstenes; Animals; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Female; Gene Expression Regulation, Neoplastic; Homosteroids; Humans; Mice; Mice, Nude; Norpregnadienes; Receptors, Progesterone; Treatment Outcome; Tumor Burden; Xenograft Model Antitumor Assays | 2016 |
Proliferation and ovarian hormone signaling are impaired in normal breast tissues from women with BRCA1 mutations: benefit of a progesterone receptor modulator treatment as a breast cancer preventive strategy in women with inherited BRCA1 mutations.
Topics: Adult; Animals; Breast; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Estradiol; Female; Genes, BRCA1; Humans; Mice; Middle Aged; Mutation; Norpregnadienes; Receptors, Estrogen; Receptors, Progesterone; Signal Transduction; Xenograft Model Antitumor Assays | 2016 |